Eric Swensen


Eric has been with the Health System's marketing department since 2006, writing for and editing a variety of publications and websites. Before working at UVA, he spent about eight years as a reporter with The Progress-Index in Petersburg, Va., The Daily Progress in Charlottesville, Va., and the News & Record in Greensboro, N.C. Eric primarily handles corporate communications and major events.

Job Title: Public Information Officer
Phone: 434.924.5770

UVA, Bon Secours to Collaborate on Liver Transplant Care

July 20, 2017

University of Virginia Health System (UVA) and the Bon Secours Liver Institute of Virginia will collaboratively care for patients at Bon Secours’ facilities in Richmond and Newport News that may need liver transplants at UVA. The Bon Secours facilities include St. Mary’s Hospital in Richmond and Mary Immaculate Hospital in Newport News.

Under the… read more >

UVA Earns National Award for Care of Heart Attack Patients

June 29, 2017

University of Virginia Health System has been recognized for its care of heart attack patients with a national award by the American College of Cardiology (ACC).

UVA was among 193 U.S. hospitals to earn the 2017 National Cardiovascular Data Registry ACTION Registry Platinum Performance Achievement Award for providing high-quality care to heart attack patients… read more >

Four UVA Children’s Hospital Specialties Nationally Ranked by U.S. News & World Report

June 27, 2017

Four specialties at University of Virginia Children’s Hospital are ranked among the top 50 nationally in the 2017-2018 “Best Children’s Hospitals” guide from U.S. News & World Report.

The four ranked specialties are:

Neonatology: 30th
Diabetes and endocrinology: 34th
Orthopedics: tied for 41st
Cardiology and heart surgery: 44th

“These national awards… read more >

UVA Honored as Center of Excellence for Bone Marrow Cancer

June 14, 2017

University of Virginia Cancer Center has earned recognition as a national center of excellence for its care of patients with myelodysplastic syndrome (MDS), a cancer of the bone marrow that often leads to leukemia.

UVA is the only center in Virginia to receive this designation from the MDS Foundation for the treatment of this… read more >

Heart Surgery Outcomes Improved After Medicaid Expansion, Study Finds

June 7, 2017

Expanding Medicaid coverage is associated with better outcomes for heart surgery patients, according to a study led by School of Medicine researchers.

Researchers examined outcomes from heart surgery quality databases in Michigan, which expanded Medicaid, and Virginia, which did not. Outcomes in both states were reviewed over the same three-year period – the 18… read more >

UVA Expanding Its Worldwide Diabetes Research and Care Model

June 6, 2017

Building on its pioneering work to better control type 1 diabetes, the University of Virginia Center for Diabetes Technology is using new UVA investment and four new team members to seek better treatments. They also plan to expand their efforts, combining their team’s research and clinical expertise with a network of knowledge from across… read more >

Heart Failure Program Earns National Quality Awards

June 5, 2017

For working to improve patients’ recovery times and reduce readmissions, the heart failure program at the University of Virginia Heart and Vascular Center has received two national quality awards from the American Heart Association.

The Advanced Heart Failure and Transplant Center earned the AHA’s 2017 Get With The Guidelines-Heart Failure Gold Plus Quality… read more >

UVA, Inova Award Research Seed Funding Grants to Joint Research Teams

May 11, 2017

The Inova Health System (Inova) and the University of Virginia (UVA) announced today that they have awarded $450,000 to nine UVA-Inova joint research teams for projects focused on how to better predict, prevent and treat disease. In the fall of 2016, Inova and UVA announced a comprehensive research and education partnership to accelerate joint… read more >

Artificial Pancreas Benefits Young Children, Trial Shows

April 28, 2017

A pilot study among young children with Type 1 diabetes found that a University of Virginia-developed artificial pancreas helped study participants better control their condition.

The goal of the artificial pancreas is to automatically monitor and regulate blood-sugar levels, eliminating the need for people with Type 1 diabetes to stick their fingers to check their blood… read more >

UVA’s Excellence in Cancer Nets $15 Million Grant

April 26, 2017

University of Virginia Cancer Center has again been honored as one of just 69 National Cancer Institute-designated cancer centers for its work researching new and better cancer treatments.

“The NCI-designated cancer centers are recognized for their scientific leadership, resources, and the depth and breadth of their research in basic, clinical, and/or population science,” according… read more >